... Capital Management increased its stake in Sanofi (SNY) by 27.71% based on its latest 2017Q4 regulatory filing with …
Parent firm Sanofi is a publicly-traded company that posted 2017 net income of $10 billion on sales of nearly $43.5 billion. Its shares closed Wednesday at $37.63, …
SNY), succeeded in the clinic. Unfortunately, commercial launches that take baby steps when investors expect giant leaps can pressure even a biotech's stock …
Sanofi's ADR has seen a five-year return of -20% ... A year later, serious accounting problems came to light, the stock plunged, and Berkshire lost about $444 million …
Regeneron Pharmaceuticals Inc and Sanofi SA will slash the price of their expensive cholesterol drug for Express Scripts Holdings Co customers in exchange for greater patient access, with some savings to be shared with consumers, the …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
(ShareCast News) - Global investor Advent International has entered into exclusive negotiations with French pharmaceutical group Sanofi about the acquisition of its European generics business, Zentiva, for €1.9bn. Advent's offer is firm, binding …